<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for POZN</title>
    <link />
    <description>Headlines for POZEN, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>POZEN Announces FDA Acceptance of Filing of New Drug Application for PA32540/PA8140 Tablets</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/29/pozen-announces-fda-acceptance-of-filing-of-new-dr/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 29 May 2013 07:50:22 GMT</pubDate>
    </item>
    <item>
      <title>POZEN to Present at the Jefferies 2013 Global Healthcare Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/23/pozen-to-present-at-the-jefferies-2013-global-heal/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 23 May 2013 07:46:54 GMT</pubDate>
    </item>
    <item>
      <title>Presence of Gastric Erosions in Patients Taking Low-Dose Aspirin for Secondary Cardiovascular Preven</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/21/presence-of-gastric-erosions-in-patients-taking-lo/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 21 May 2013 07:43:15 GMT</pubDate>
    </item>
    <item>
      <title>Pozen Stock Sees Short Interest Increase 19.5%</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11920451/1/pozen-stock-sees-short-interest-increase-195.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 15:33:00 GMT</pubDate>
    </item>
    <item>
      <title>POZEN's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1416161-pozen-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 17:21:04 GMT</pubDate>
    </item>
    <item>
      <title>Pounding The Table On Pozen: Why There's Upside In This Misunderstood Name</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1415031-pounding-the-table-on-pozen-why-there-s-upside-in-this-misunderstood-name.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 14:30:36 GMT</pubDate>
    </item>
    <item>
      <title>POZEN Reports First Quarter 2013 Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/pozen-reports-first-quarter-2013-results/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 07:50:24 GMT</pubDate>
    </item>
    <item>
      <title>POZEN Announces May 8th Webcast of First Quarter 2013 Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/30/pozen-announces-may-8th-webcast-of-first-quarter-2/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 30 Apr 2013 07:49:50 GMT</pubDate>
    </item>
    <item>
      <title>POZEN's CEO Hosts Analyst and Investor Update Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1352741-pozen-s-ceo-hosts-analyst-and-investor-update-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 16:26:04 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Under $10 Set to Soar</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-under-10-set-soar.html-24.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 18 Apr 2013 13:11:00 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Lows</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3475108/stocks-hitting-52-week-lows.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 05 Apr 2013 12:41:17 GMT</pubDate>
    </item>
    <item>
      <title>POZEN Announces Results from a Burden of Cardiovascular Disease Study: a Managed Care Perspective</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/05/pozen-announces-results-from-a-burden-of-cardiovas/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 05 Apr 2013 10:51:07 GMT</pubDate>
    </item>
    <item>
      <title>POZEN Inc. Stock Downgraded (POZN)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11885933/1/pozen-inc-stock-downgraded-pozn.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 03 Apr 2013 05:00:00 GMT</pubDate>
    </item>
    <item>
      <title>POZEN Submits New Drug Application for PA32540/PA8140</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/27/pozen-submits-new-drug-application-for-pa32540pa81/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 27 Mar 2013 07:50:24 GMT</pubDate>
    </item>
    <item>
      <title>POZEN Submits NDA for PA32540/PA8140</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3450263/pozen-submits-nda-for-pa32540pa8140.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 27 Mar 2013 07:32:33 GMT</pubDate>
    </item>
    <item>
      <title>POZEN Reports European Patent Office Maintains PA/VIMOVO Patent</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/12/pozen-reports-european-patent-office-maintains-pav/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 12 Mar 2013 08:05:12 GMT</pubDate>
    </item>
    <item>
      <title>European Patent Office Maintains POZEN PA/VIMOVO Patent</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3407734/european-patent-office-maintains-pozen-pavimovo-patent.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 12 Mar 2013 07:37:44 GMT</pubDate>
    </item>
    <item>
      <title>Zacks Reiterates Outperform Rating, $9.50 PT on POZEN on PA-325/40 Product Data Presentations</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3395552/zacks-reiterates-outperform-rating-9-50-pt-on-pozen-on-p.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 06 Mar 2013 14:12:24 GMT</pubDate>
    </item>
    <item>
      <title>A Deal For Pozen's PA Could Send Shares Soaring</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1252041-a-deal-for-pozen-s-pa-could-send-shares-soaring.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Mar 2013 13:48:50 GMT</pubDate>
    </item>
    <item>
      <title>POZEN's CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1251851-pozen-s-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Mar 2013 13:07:01 GMT</pubDate>
    </item>
  </channel>
</rss>
